Indivior Pharmaceuticals (INDV) Intangibles (2021 - 2023)

Indivior Pharmaceuticals' Intangibles history runs 3 years deep, the most recent figure standing at $237.0 million for Q4 2023.

• On a quarterly basis, Intangibles rose 238.57% year-over-year to $237.0 million in Q4 2023; TTM through Dec 2023 was $237.0 million, a 238.57% increase from a year earlier, with the FY2023 full-year figure at $237.0 million, up 238.57% from the prior year.
• Intangibles climbed to $237.0 million in Q4 2023 per INDV's latest filing, from $70.0 million in the prior quarter.
• Across five years, Intangibles topped out at $237.0 million in Q4 2023 and bottomed at $70.0 million in Q4 2022.
• The 3-year median for Intangibles is $82.0 million (2021), against an average of $129.7 million.
• Across the five-year window, Intangibles decreased 14.63% in 2022 and soared 238.57% in 2023, its largest moves.
• Year by year, Intangibles stood at $82.0 million in 2021, then fell by 14.63% to $70.0 million in 2022, then surged by 238.57% to $237.0 million in 2023.
• Per Business Quant, the three latest INDV Intangibles figures stand at $237.0 million (Q4 2023), $70.0 million (Q4 2022), and $82.0 million (Q4 2021).